Can PathoCare’s $1.75bn tender offer reprice the future of AI-driven diagnostics?
Find out why PathoCare's $1.75B valuation and expanded $50M financing round could signal a breakthrough moment for AI-powered point-of-care diagnostics.
Medical Devices & Diagnostics